AbCellera Biologics
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Business Model:
Revenue: $718M
Employees: 201-500
Rankings
Industries / Tags:
Detailed AbCellera Biologics Information
Geographic Data
Address: 2215 Yukon Street
City: Vancouver
State: british columbia
Zip: V5Y 0A1
Country: CA
Financial Info
Stage:
Raised Last:
$105M
Raised Total:$371M
Social
Twitter
Linkedin
Crunchbase
Metrics
1,150,143Website Global Rank
31,704Website Monthly Traffic
Twitter Followers
Description
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
Contact Phone:
+16045599005
Contact Email:
AbCellera Biologics went public on 12/10/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/10/2020
IPO Valuation:
$5B
Ticker Symbol:
ABCL
IPO Price:
$20/share
Amount Raised:
$482M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
